Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors.

Frontiers in oncology（2023）

引用 1|浏览5

暂无评分

摘要

EDITORIAL article Front. Oncol., 28 March 2023Sec. Pharmacology of Anti-Cancer Drugs Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1180650

查看译文

关键词

CDK,Rb,combination,pre-clinical,solid tumors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要